
Understanding Short QT Syndrome: Diagnosing and Using Genetic Testing
A QT interval under 330 milliseconds on an ECG can signal short QT syndrome, an autosomal dominant condition linked to KCNH2, KCNQ1 and KCNJ2 variants.

MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.

A QT interval under 330 milliseconds on an ECG can signal short QT syndrome, an autosomal dominant condition linked to KCNH2, KCNQ1 and KCNJ2 variants.

Changes in bowel habits, blood in the stool and weight loss can signal cancer of the sigmoid colon; colonoscopy confirms it and APC, KRAS or TP53 testing guides care.

Thrashing or kicking episodes during sleep can be mistaken for night terrors; video-EEG, polysomnography and CHRNA4, CHRNB2 and KCNT1 testing help confirm SHE.

Discover the causes, diagnosis, and the role of genetic testing in managing small vessel cerebrovascular disease. Learn about symptoms, imaging, and personalized treatments.

Stiff, jerky movements follow damage to the developing brain; medical history, physical examination and MRI or CT imaging lead to a diagnosis of spastic cerebral palsy.

Loss of motor neurons in the spinal cord and brainstem weakens muscles; a blood test for SMN1 mutations confirms SMA and supports carrier, prenatal and newborn screening.

Diagnosing Spinocerebellar Atrophy: Understand symptoms, clinical exams, and how genetic testing plays a crucial role in managing this hereditary neurological disorder.

Malformed vertebrae and ribs can restrict lung growth and cause scoliosis in spondylocostal dysostosis; DLL3, MESP2, LFNG and HES7 are among the genes tested.